Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 2
1961 1
1962 1
1963 2
1965 4
1966 1
1967 2
1968 4
1969 3
1973 1
1976 2
1977 5
1978 3
1979 2
1980 1
1981 1
1982 3
1983 3
1984 1
1986 3
1987 3
1988 3
1989 6
1990 4
1991 2
1992 5
1993 3
1994 4
1995 1
1997 3
1998 4
1999 1
2000 5
2001 4
2002 5
2003 2
2004 7
2005 8
2006 10
2007 10
2008 9
2009 18
2010 17
2011 20
2012 19
2013 15
2014 27
2015 27
2016 42
2017 28
2018 18
2019 21
2020 41
2021 35
2022 31
2023 32
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Results by year

Filters applied: . Clear all
Page 1
A genetically encoded fluorescent sensor for in vivo imaging of GABA.
Marvin JS, Shimoda Y, Magloire V, Leite M, Kawashima T, Jensen TP, Kolb I, Knott EL, Novak O, Podgorski K, Leidenheimer NJ, Rusakov DA, Ahrens MB, Kullmann DM, Looger LL. Marvin JS, et al. Among authors: shimoda y. Nat Methods. 2019 Aug;16(8):763-770. doi: 10.1038/s41592-019-0471-2. Epub 2019 Jul 15. Nat Methods. 2019. PMID: 31308547
Optogenetic stimulus-triggered acquisition of seizure resistance.
Shimoda Y, Beppu K, Ikoma Y, Morizawa YM, Zuguchi S, Hino U, Yano R, Sugiura Y, Moritoh S, Fukazawa Y, Suematsu M, Mushiake H, Nakasato N, Iwasaki M, Tanaka KF, Tominaga T, Matsui K. Shimoda Y, et al. Neurobiol Dis. 2022 Feb;163:105602. doi: 10.1016/j.nbd.2021.105602. Epub 2021 Dec 24. Neurobiol Dis. 2022. PMID: 34954320 Free article.
MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals.
Ozawa N, Yokobori T, Osone K, Bilguun EO, Okami H, Shimoda Y, Shiraishi T, Okada T, Sano A, Sakai M, Sohda M, Miyazaki T, Ide M, Ogawa H, Yao T, Oyama T, Shirabe K, Saeki H. Ozawa N, et al. Among authors: shimoda y. Int J Cancer. 2024 Jan 15;154(2):359-371. doi: 10.1002/ijc.34722. Epub 2023 Sep 7. Int J Cancer. 2024. PMID: 37676657
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations.
Ohshima K, Nagashima T, Fujiya K, Hatakeyama K, Watanabe Y, Morimoto K, Kamada F, Shimoda Y, Ohnami S, Naruoka A, Serizawa M, Ohnami S, Kenmotsu H, Shiomi A, Tsubosa Y, Bando E, Sugiura T, Sugino T, Terashima M, Uesaka K, Urakami K, Akiyama Y, Yamaguchi K. Ohshima K, et al. Among authors: shimoda y. Cancer Res Commun. 2023 Apr 24;3(4):684-696. doi: 10.1158/2767-9764.CRC-22-0364. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37377752 Free PMC article.
Generation of novel complete HLA class I monoallelic cell lines used in an MHC stabilization assay for neoantigen evaluation.
Iizuka A, Akiyama Y, Sakura N, Kanematsu A, Kikuchi Y, Nagashima T, Urakami K, Shimoda Y, Ohshima K, Shiomi A, Ohde Y, Terashima M, Uesaka K, Mukaigawa T, Hirashima Y, Yoshikawa S, Katagiri H, Sugino T, Takahashi M, Kenmotsu H, Yamaguchi K. Iizuka A, et al. Among authors: shimoda y. Oncol Lett. 2023 Jun 13;26(2):324. doi: 10.3892/ol.2023.13910. eCollection 2023 Aug. Oncol Lett. 2023. PMID: 37415627 Free PMC article.
Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C, Iizuka A, Ikeya T, Miyata H, Maeda C, Ashizawa T, Nagashima T, Urakami K, Shimoda Y, Ohshima K, Muramatsu K, Sugino T, Shiomi A, Ohde Y, Bando E, Furukawa K, Sugiura T, Mukaigawa T, Nishimura S, Hirashima Y, Mitsuya K, Yoshikawa S, Tsubosa Y, Katagiri H, Niwakawa M, Yamaguchi K, Kenmotsu H, Akiyama Y. Hozumi C, et al. Among authors: shimoda y. Cancer Genomics Proteomics. 2024 Jan-Feb;21(1):88-101. doi: 10.21873/cgp.20432. Cancer Genomics Proteomics. 2024. PMID: 38151294 Free PMC article.
Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non-small cell lung cancer patients.
Torasawa M, Yoshida T, Takeyasu Y, Shimoda Y, Tateishi A, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yamamoto N, Takahashi K, Ohe Y. Torasawa M, et al. Among authors: shimoda y. Cancer Med. 2023 Jun;12(11):12388-12401. doi: 10.1002/cam4.5939. Epub 2023 Apr 16. Cancer Med. 2023. PMID: 37062059 Free PMC article.
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations.
Shimoda Y, Yoshida T, Miyakoshi J, Torasawa M, Tateishi A, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yamamoto N, Ohe Y. Shimoda Y, et al. Cancer Immunol Immunother. 2023 Aug;72(8):2613-2621. doi: 10.1007/s00262-023-03429-z. Epub 2023 Apr 16. Cancer Immunol Immunother. 2023. PMID: 37062033
Clinical Impact of Surgical Sarcopenia on Long-term Survival.
Komori K, Kano K, Aoyama T, Hara K, Nagasawa S, Nakazono M, Shimoda Y, Maezawa Y, Kumazu Y, Kawabe T, Numata M, Hayashi T, Yamada T, Tamagawa H, Sato T, Cho H, Yukawa N, Rino Y, Yoshikawa T, Ogata T, Oshima T. Komori K, et al. Among authors: shimoda y. Anticancer Res. 2022 Sep;42(9):4545-4552. doi: 10.21873/anticanres.15957. Anticancer Res. 2022. PMID: 36039446
482 results